Moderna jumped 177% after positive phase 3 results for its personalized mRNA cancer therapy, the first readout of its kind. The news lifted biotech stocks and s

BWB News TV • 2026-08-23 19:46 UTC • By Billy Odell Tucker-Robinson

Moderna jumped 177% after positive phase 3 results for its personalized mRNA cancer therapy, the first readout of its kind. The news lifted biotech stocks and sent Merck to a record high, boosting focus on mRNA cancer vaccines.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly